US$ 27.07
glp 1 agonist medicine GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders GLP-1 Receptor Agonists and Research
Description
placebo (1:1:1:1) for the treatment of obesity

Footnotes Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article
Ann Intern Med 141(11):84650

Consistent with this concept, GLP-1RAs have been shown to directly modulate immune responses by reducing the secretion of key pro-inflammatory cytokines such as IL-6 and TNF-, which are central drivers of inflammation in both PsO and PsA (70, 71)
